ストックスクリーナーアプリを入手
1.35
3.85%
0.05
アフターアワーズ：
1.33
-0.02
-1.48%
Pacific Biosciences Of California Inc (PACB) 最新ニュース
Pacific Biosciences (PACB) Up 11.6% Since Last Earnings Report: Can It Continue? - finance.yahoo.com
PacBio to Participate in the Morgan Stanley 24?? Annual Global Healthcare Conference - marketscreener.com
PACB stock gains as PacBio highlights sequencing strength ahead Morgan Stanley conference - AD HOC NEWS
PacBio to Participate in the Morgan Stanley 24ᵗʰ Annual Global Healthcare Conference - marketscreener.com
10x Genomics Rallies 84% in 3 Months: Is There More Upside Ahead? - tradingview.com
PACB Cuts 2026 Outlook as Clinical Adoption Faces Its Crucial Test - tradingview.com
3 Reasons to Sell PACB and 1 Stock to Buy Instead - Yahoo Finance
Pacific Biosciences (PACB) Tumbles 9.7% to $1.40, Nears Critical Support at $1.33Stock News - vinanet.vn
PACB Stock Pops As New CEO Backs Powerful Vega Upgrade - stockstotrade.com
Pacific Biosciences of California, Inc. (NASDAQ:PACB) Given Average Recommendation of "Reduce" by Analysts - MarketBeat
Pacific (PACB) Earnings Update: EPS Misses Its Estimate on the Day; Trading Response: Shares Close 11.40% Higher in Latest TradingEarnings Weakness Phase - Vinanet
Pacific Biosciences CEO Mark van Oene sells $30,409 in stock By Investing.com - Investing.com South Africa
Pacific Biosciences of California (PACB) Institutional Ownership 2026 - MarketBeat
Pacific Biosciences CEO Mark van Oene sells $30,409 in stock - Investing.com
Insider Selling: Pacific Biosciences of California (NASDAQ:PACB) Insider Sells 26,911 Shares of Stock - MarketBeat
PacBio (NASDAQ: PACB) CEO share sale covers RSU tax withholding - Stock Titan
Pacific Biosciences of California Inc (HAM:P09) Stock Price, Trades & News - GuruFocus
Pacific Biosciences of California Inc (PACB) (Q2 2026) Earnings - GuruFocus
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. SEC Filing (Aug 17, 2026) - Stock Titan
PacBio Cuts Outlook as SPRQ-Nx Transition Slows, Targets 2028 Cash-Flow Positivity - MarketBeat
ARK reports 9.59% stake in Pacific Biosciences (PACB) - Stock Titan
5 Must-Read Analyst Questions From PacBio’s Q2 Earnings Call - Yahoo Finance
PACIFIC BIOSCIENCES (PACB) CEO granted 1.97M options and 489K RSUs - Stock Titan
Measuring – not guessing – the true path - PacBio
Weekly Recap: PACB cuts 2026 revenue guide and Mark Van Oene named CEO - TradingView
Pacific Biosciences of California, Inc. $PACB Shares Sold by Renaissance Technologies LLC - MarketBeat
Pacific Biosciences of California, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:PACB) 2026-08-08 - Seeking Alpha
Earnings Release: Here's Why Analysts Cut Their Pacific Biosciences of California, Inc. (NASDAQ:PACB) Price Target To US$2.29 - simplywall.st
Pacific Biosciences of California (NASDAQ:PACB) Cut to "Sell" at Wall Street Zen - MarketBeat
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. 2026: Revenue $39.01M, EPS ($0.14) — 10-Q Summary - TradingView
Pacific Biosciences of California, Inc. Stock 12‑Month Price Target Cut to $2.29, Implies 76% Upside - TradingView
TD Cowen Maintains Pacific Biosciences of California(PACB.US) With Buy Rating, Maintains Target Price $3 - Moomoo
PacBio Q2 Earnings Meet Estimates, Revenues Miss, 2026 Sales View Cut - Yahoo Finance
Pacific Biosciences: It's Only Getting Worse (NASDAQ:PACB) - Seeking Alpha
Pacific Biosciences of California Q2 Earnings Call Highlights - TradingView
Pacific Biosciences of California, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
Pacific Biosciences of California Appoints New CEO, Plans to Cut 8% of Workforce - Moomoo
Pacific Biosciences of California (PACB) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance
PacBio Q2 2026 slides: SPRQ-Nx launch amid revenue miss, cut guidance - Investing.com
Is Pacific Biosciences (PACB) Positioned for Growth After Q2 Ear - GuruFocus
PacBio (NASDAQ:PACB) Reports Sales Below Analyst Estimates In Q2 CY2026 Earnings - Barchart.com
Pacific Biosciences of CaliforniaEstimates - Moomoo
PacBio names Mark Van Oene as CEO, replacing Christian Henry By Investing.com - Investing.com South Africa
PACIFIC BIOSCIENCES OF CALIFORNIACHRISTIAN HENRY STEPS DOWN AS PRESIDENT AND CEO - moomoo.com
PacBio Appoints Mark Van Oene as President and Chief Executive Officer - The Manila Times
Pacbio Appoints Mark Van Oene as President an - Moomoo
Pacific Biosciences Announces Restructuring Plan, Cutting 8% of Workforce to Drive Up to $40 Million in Annual Savings by 2027 - marketscreener.com
PacBio Announces Second Quarter 2026 Financial Results - The Manila Times
Press Release: PacBio Appoints Mark Van Oene as President and Chief Executive Officer - Moomoo
Pacific Biosciences of California, Inc. Provides Revenue Guidance for the Full Year of 2026 - marketscreener.com
PacBio Vega adds two- and four-hour runs for short-insert DNA - Stock Titan
GenomOncology and PacBio Launch Integrated Oncology Sequencing Workflow - Clinical Lab Products
Pacific Biosciences of California, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
PacBio (PACB) To Report Earnings Tomorrow: Here Is What To Expect - barchart.com
0.86%
0.13%
大文字化:
|
ボリューム (24 時間):